Suppr超能文献

不孕症女性中的亚临床甲状腺功能减退和甲状腺自身免疫

Subclinical hypothyroidism and thyroid autoimmunity in women with infertility.

作者信息

Abalovich Marcos, Mitelberg Laura, Allami Carlos, Gutierrez Silvia, Alcaraz Graciela, Otero Patricia, Levalle Oscar

机构信息

Human Reproduction and Thyroid Sections, Endocrinology Division, Hospital Carlos Durand, Buenos Aires, Argentina.

出版信息

Gynecol Endocrinol. 2007 May;23(5):279-83. doi: 10.1080/09513590701259542.

Abstract

OBJECTIVE

To determine the prevalence of different subclinical hypothyroidism (SH) grades and thyroid autoimmunity (TAI) in infertile women.

DESIGN

Retrospective study. Setting. Endocrinology division of a public hospital in Argentina.

PATIENTS

Group I comprised 244 women consulting on infertility (>1 year without pregnancy); Group C (controls) comprised 155 healthy women with confirmed fertility.

INTERVENTION

Thyroid-stimulating hormone and thyroid peroxidase antibodies were measured in all patients, and a thyrotropin-releasing hormone (TRH) stimulation test was performed in 71 patients to diagnose SH grade 1. The pregnancy rate in hypothyroid women on levothyroxine treatment was also evaluated.

RESULTS

SH was diagnosed in 13.9% of the patients in Group I and in 3.9% of Group C (p < 0.002). The TRH stimulation test was useful to detect SH grade 1 in 12.7% of the infertile patients. Patients with precocious ovarian failure, tubal disturbances and ovulatory dysfunction presented higher SH rates (40.0, 18.2 and 15.4%, respectively) than control patients (p < 0.0001, p < 0.002 and p < 0.003). No significant difference in TAI prevalence was shown in Group I relative to Group C. Pregnancy rate of 44.1% was achieved under levothyroxine treatment.

CONCLUSIONS

We observed a higher prevalence of SH, but not of TAI, in patients with infertility. Our results support thyroid screening in women with reproductive failure.

摘要

目的

确定不孕女性中不同亚临床甲状腺功能减退(SH)分级和甲状腺自身免疫(TAI)的患病率。

设计

回顾性研究。地点:阿根廷一家公立医院的内分泌科。

患者

第一组包括244名咨询不孕问题的女性(未怀孕超过1年);C组(对照组)包括155名已证实有生育能力的健康女性。

干预措施

对所有患者测量促甲状腺激素和甲状腺过氧化物酶抗体,并对71名患者进行促甲状腺激素释放激素(TRH)刺激试验以诊断1级SH。还评估了接受左甲状腺素治疗的甲状腺功能减退女性的妊娠率。

结果

第一组中13.9%的患者被诊断为SH,C组为3.9%(p<0.002)。TRH刺激试验有助于在12.7%的不孕患者中检测出1级SH。卵巢早衰、输卵管疾病和排卵功能障碍患者的SH发生率(分别为40.0%、18.2%和15.4%)高于对照组患者(p<0.0001、p<0.002和p<0.003)。第一组与C组相比,TAI患病率无显著差异。左甲状腺素治疗后的妊娠率为44.1%。

结论

我们观察到不孕患者中SH的患病率较高,但TAI并非如此。我们的结果支持对生殖功能衰竭女性进行甲状腺筛查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验